PFIZER
Back to Balance Sheet
|
PFIZER Last 5 Year Total Non-Current Liabilities History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹19 Cr | ₹55 Cr | ₹33 Cr | ₹38 Cr | ₹136 Cr |
What is the latest Total Non-Current Liabilities ratio of PFIZER ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2026 | ₹19 Cr |
| Mar2025 | ₹55 Cr |
| Mar2024 | ₹33 Cr |
| Mar2023 | ₹38 Cr |
| Mar2022 | ₹136 Cr |
How is Total Non-Current Liabilities of PFIZER Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹19 Cr | -65.04 | |
| Mar2025 | ₹55 Cr | 67.65 | |
| Mar2024 | ₹33 Cr | -14.76 | |
| Mar2023 | ₹38 Cr | -71.81 | |
| Mar2022 | ₹136 Cr | - | |
Compare Total Non-Current Liabilities of peers of PFIZER
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PFIZER | ₹17,888.1 Cr | -2.6% | -16.7% | -21% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹446,276.0 Cr | -0.3% | -3.1% | 12.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹251,531.0 Cr | -1.3% | 2.2% | 57.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹186,957.0 Cr | -1.3% | -2.4% | 33.3% | Stock Analytics | |
| CIPLA | ₹111,729.0 Cr | 0.2% | -2.5% | -9.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹104,335.0 Cr | 3.3% | 6.1% | -6.5% | Stock Analytics | |
PFIZER Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PFIZER | -2.6% |
-16.7% |
-21% |
| SENSEX | -2.7% |
-5.7% |
-11.7% |
You may also like the below Video Courses